Literature DB >> 21344355

Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction.

Christine Sempoux1, Cathy Fan, Paramjeet Singh, Khaled Obeidat, Sasan Roayaie, Myron Schwartz, Maria Isabel Fiel, Swan N Thung.   

Abstract

The authors present an interesting case of a 60-year-old man who underwent right hepatectomy for a diagnosis of hepatocellular carcinoma (HCC) on a background of noncirrhotic chronic hepatitis C. Pathologic examination confirmed the presence of HCC near the porta hepatis, which invaded the right portal vein branch. In addition, a well-demarcated 13.5 × 7.8 × 4.0 cm yellow and firm area upstream of the HCC was noted. This yellow area corresponded to a tumoral ductular proliferation, which cytologically was extremely bland, but invaded portal tracts and the adjacent liver parenchyma. This tumoral proliferation mimicked ductular reaction, except that it had more anastomosing structures and was associated with abundant hyalinized fibrotic stroma. Cytologically, the tumor cells had round to oval nuclei with fine chromatin, indistinct nucleoli, and scant cytoplasm. They exhibited immunohistochemical features of hepatic progenitor cells, i.e., expressing CK7, CK19, and N-CAM; and their malignancy was supported by the p53 and Ki67 immunoreactivity. The authors concluded that the patient had cholangiolocellular carcinoma with an aggressive hepatocellular carcinoma component. Cholangiolocellular carcinoma has been reported to be associated with chronic hepatitis C viral infection and to derive from hepatic progenitor cells, which explains why hepatocellular carcinoma and/or cholangiocarcinoma component may be present. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21344355     DOI: 10.1055/s-0031-1272838

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  12 in total

1.  Proliferative index facilitates distinction between benign biliary lesions and intrahepatic cholangiocarcinoma.

Authors:  Christos G Tsokos; Gregor Krings; Funda Yilmaz; Linda D Ferrell; Ryan M Gill
Journal:  Hum Pathol       Date:  2016-07-07       Impact factor: 3.466

Review 2.  Pathology of intrahepatic cholangiocarcinoma.

Authors:  Sandrine Vijgen; Benoit Terris; Laura Rubbia-Brandt
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

Review 3.  Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.

Authors:  Elizabeth M Brunt; Valerie Paradis; Christine Sempoux; Neil D Theise
Journal:  Hepat Oncol       Date:  2015-07-28

4.  Characterization of liver injury, oval cell proliferation and cholangiocarcinogenesis in glutathione S-transferase A3 knockout mice.

Authors:  Dana R Crawford; Zoran Ilic; Ian Guest; Ginger L Milne; John D Hayes; Stewart Sell
Journal:  Carcinogenesis       Date:  2017-07-01       Impact factor: 4.944

Review 5.  Cholangiocarcinoma: novel therapeutic targets.

Authors:  Keisaku Sato; Shannon Glaser; Domenico Alvaro; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Expert Opin Ther Targets       Date:  2020-02-26       Impact factor: 6.902

6.  Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.

Authors:  Shoji Kubo; Hiroji Shinkawa; Yoshinari Asaoka; Tatsuya Ioka; Hiroshi Igaki; Namiki Izumi; Takao Itoi; Michiaki Unno; Masayuki Ohtsuka; Takuji Okusaka; Masumi Kadoya; Masatoshi Kudo; Takashi Kumada; Norihiro Kokudo; Michiie Sakamoto; Yoshihiro Sakamoto; Hideyuki Sakurai; Tadatoshi Takayama; Osamu Nakashima; Yasushi Nagata; Etsuro Hatano; Kenichi Harada; Takamichi Murakami; Masakazu Yamamoto
Journal:  Liver Cancer       Date:  2022-02-23       Impact factor: 12.430

7.  Giant Cholangiolocellular Carcinoma With Early Recurrence That Was Difficult to Distinguish From Cholangiocellular Carcinoma: Report of a Case.

Authors:  Norihiro Ishii; Hideki Suzuki; Mariko Tsukagoshi; Akira Watanabe; Norio Kubo; Kenichiro Araki; Satoshi Wada; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2015-06

8.  Connective tissue growth factor and integrin αvβ6: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice.

Authors:  Liya Pi; Paulette M Robinson; Marda Jorgensen; Seh-Hoon Oh; Alicia R Brown; Paul H Weinreb; Thu Le Trinh; Protopapadakis Yianni; Chen Liu; Andrew Leask; Shelia M Violette; Edward W Scott; Gregory S Schultz; Bryon E Petersen
Journal:  Hepatology       Date:  2015-02       Impact factor: 17.425

Review 9.  What are the precursor and early lesions of peripheral intrahepatic cholangiocarcinoma?

Authors:  Yasuni Nakanuma; Akemi Tsutsui; Xiang Shan Ren; Kenichi Harada; Yasunori Sato; Motoko Sasaki
Journal:  Int J Hepatol       Date:  2014-04-22

10.  Dramatic response to dabrafenib and trametinib combination in a BRAF V600E-mutated cholangiocarcinoma: implementation of a molecular tumour board and next-generation sequencing for personalized medicine.

Authors:  Arturo Loaiza-Bonilla; Erica Clayton; Emma Furth; Mark O'Hara; Jennifer Morrissette
Journal:  Ecancermedicalscience       Date:  2014-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.